About Lab M
Lab M is a Healthcare company based in Heywood (United Kingdom) founded in 1971, and was acquired by NeoGen Labs in August 2015. It manufactures microbiology products. Its chief executive is Ian Morris.
Company details
Lab M specializes in the development and manufacturing of microbiological culture media and other microbiology products. The product portfolio of the company includes dehydrated culture media, harmonized pharmacopeia Pinnacle, pre-poured plates, µPREP, captivate, nutriTone, neogen, supplements additives, prepared media, swabs, and laboratory consumables.
- Headquarters Heywood, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website labm.com
- Social LinkedIn X
- Acquired by NeoGen Labs (Aug 2015)
- Investors
- Acquired byNeoGen Labs
(Aug 2015)
Investors in Lab M
Lab M has secured backing from 1 investor. Prominent investors backing the company include NeoGen Labs.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Neonatal diagnostic solutions for the detection of inborn errors of metabolism | 2006 | neogenlabs.com | Bengaluru, India |
Investor details for Lab M
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Lab M
1 people are tracked at Lab M (1 in leadership).
| Name | Role | Group |
|---|---|---|
Ian Morris | CEO & MD | Leadership |
Complete people profiles for Lab M
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Lab M
2 dated milestones of Lab M across 44 years, from founding to its latest funding, stage changes and deals.
- Founded Lab M is founded.
- Exit Acquired by NeoGen Labs.
Web traffic of Lab M
The website of Lab M (labm.com) receives about 2.1K visits a month.
- Monthly visits2.1K
▲ 2.8% vs previous month
Websites whose visitors overlap most with Lab M. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| condalab.com | 100% | – | #726,805 | View details | |
| oxoid.com | 90% | – | – | View details | |
scharlabmagyarorszag.hu | scharlabmagyarorszag.hu | 84% | – | #7,755,001 | – |
bio-world.com | bio-world.com | 82% | – | #901,632 | – |
| himedialabs.com | 80% | 284.7K | #167,428 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for Lab M
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Lab M (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lab M
Lab M was founded in 1971.
Lab M is headquartered in Heywood, United Kingdom. It is registered at Heywood, England, United Kingdom.
Ian Morris is the current CEO of Lab M.
Lab M specializes in the development and manufacturing of microbiological culture media and other microbiology products. The product portfolio of the company includes dehydrated culture media, harmonized pharmacopeia Pinnacle, pre-poured plates, µPREP, captivate, nutriTone, neogen, supplements additives, prepared media, swabs, and laboratory consumables.
Lab M has 1 investor. Key investors include NeoGen Labs.
Yes. Lab M was acquired by NeoGen Labs in August 2015.